Across
- 1. Adjunctive drug for severe heart failure. Reduces heart rate. Reduces myocardial demand. Reduces hospitalization for patients with severe heart failure with significantly reduced ejection fraction.
- 4. Abbreviation. Diuretic. Short-term treatment of malignant hypertension.
- 5. Most commonly used phosphodiesterase 3 inhibitor. Short-term management of acute to severe heart failure.
- 9. Potent vasodilator on arterioles and venules. Metabolized to thiocyanate.
- 12. Relates to or influencing the force of myocardial contraction.
- 13. A visual disturbance. Intermittent enhanced brightness in a limited area of the visual field. Halos. Multiple images.
Down
- 2. _____ shock. Massive vasodilation due to release of histamine in response to severe allergy.
- 3. Prototype. Cardiac glycoside. Improves contractility. Slows the rate of ventricular contraction.
- 6. _____ shock. When mass or fluid accumulation and/or blood clot outside the heart interferes with the heart’s ability to pump blood. Pulmonary embolism. Constrictive pericarditis. Restrictive cardiomyopathy.
- 7. Breaks down the natriuretic peptide.
- 8. _____ adrenergic blockers. Useful in the treatment of hypertension in patients with ischemic heart disease. Useful among lee than 50 years of age with acute coronary syndrome or recent MI and heart failure with reduced ejection fraction.
- 10. _____ phenomenon. Orthostatic hypotension with palpitation, dizziness, and syncope 1-3 hours after the initial dose or increased dose.
- 11. Prototype. Adrenergic drug. Increases blood pressure. Increases heart rate, force of contraction, or cardiac output.